Linking Systemic Inflammation to Coronary Lesion Complexity: A Combined FFR and OCT Study

Nicoleta-Monica Popa-Fotea1,2, Miruna-Mihaela Micheu2, Lucian Calmac1,2

  • 1Department of Cardiology, University of Medicine and Pharmacy Carol Davila, 8, Eroii Sanitari, 050474 Bucharest, Romania.

Insights

Higher levels of inflammatory biomarkers interleukin-1 receptor antagonist (IL-1ra), resistin, and C-reactive protein (CRP) are linked to more complex coronary artery disease in acute coronary syndrome (ACS) patients. This suggests inflammatory markers can help assess ACS risk and vulnerability.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Atherosclerosis Research

Background:

  • Residual inflammation post-acute coronary syndrome (ACS) drives atherosclerosis progression and plaque instability.
  • Key inflammatory biomarkers like interleukin-1 receptor antagonist (IL-1ra), resistin, and C-reactive protein (CRP) may indicate coronary lesion complexity and vulnerability.

Purpose of the Study:

  • To assess the association between IL-1ra, resistin, and CRP levels with coronary disease extent, functional significance of non-culprit lesions (FFR), and plaque vulnerability (OCT-defined TCFA) in ACS patients.

Main Methods:

  • Prospective study of 93 ACS patients undergoing invasive coronary assessment.
  • Measured inflammatory biomarkers at admission and 6 months.
  • Stratified patients into tertiles by biomarker levels.
  • Assessed coronary disease extent (SYNTAX score), lesion significance (FFR), and plaque morphology (OCT-defined TCFA).
  • Utilized multivariate logistic regression analysis.

Main Results:

  • Higher tertiles of IL-1ra, resistin, and CRP correlated with increased SYNTAX scores, reduced FFR (<0.80), and higher prevalence of thin-cap fibroatheroma (TCFA).
  • Specifically, 68% in the highest tertile had FFR < 0.80, and 62% had TCFA compared to 20% in lower tertiles.
  • IL-1ra, resistin, and CRP independently predicted high-risk coronary profiles in multivariate models.

Conclusions:

  • IL-1ra, resistin, and CRP are independently associated with coronary lesion complexity, functional significance, and vulnerability in ACS patients.
  • Inflammatory biomarker profiling offers a complementary approach to anatomical and physiological assessments for ACS risk stratification.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
470
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
313
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450